Brooker RC, Schache AG, Sacco JJ. NICO Phase II clinical trial - focus on an emerging immunotherapy strategy for the adjuvant treatment of locally-advanced oral cancers. Br J Oral Maxillofac Surg 2021;59:959-962.
PMID: 34325944